Products
Product Name | CAS No. | Specification | Application | Registration |
Cagrilintide | 1415456-99-3 | 98+% | Research on the treatment of diabetes | CGRP Receptor | |
Ruxolitinib phosphate | 1092939-17-7 | 99+% | ||
Staurosporine | 62996-74-1 | 98+% | Anticancer Research | Antineoplastic and Immunosuppressive Antibiotics inhibitor | PKC inhibitor | |
Midostaurin | 120685-11-2 | 98+% | Anticancer Research | |
Hidrosmin | 115960-14-0 | 90+% | Research on Venous Insufficiency and Diabetes | |
Perilla Leaf Oil | 68153-38-8 | 98+% | ||
Azvudine | 1011529-10-4 | 98+% | Reverse Transcriptase | |
Melatonin | 73-31-4 | 98+% | Ingredient of health care products. | |
Calicheamicin | 108212-75-5 | 98+% | Tumor antibiotics | |
N-Acetyl-Calicheamicin | 108212-76-6 | 98+% | Cancer Targeted Therapy | |
Fludarabine Phosphate | 75607-67-9 | 98+% | DNA/RNA Synthesis inhibitor | |
Fludarabine | 21679-14-1 | 98+% | Antineoplastic Agents | |
Merafloxacin | 91188-00-0 | 98+% | COVID-19 inhibitor | SARS-CoV inhibitor | Bacterial inhibitor | |
Azacitidine | 320-67-2 | 98+% | DNA Methyltransferase | |
Pemetrexed Disodium Heptahydrate | 357166-29-1 | 98+% | Antifolate |